Compare HCAT & ARAY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | HCAT | ARAY |
|---|---|---|
| Founded | 2008 | 1990 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Computer Software: Programming Data Processing | Medical/Dental Instruments |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 174.0M | 170.1M |
| IPO Year | 2019 | 2007 |
| Metric | HCAT | ARAY |
|---|---|---|
| Price | $2.72 | $1.03 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 11 | 2 |
| Target Price | $4.30 | ★ $4.50 |
| AVG Volume (30 Days) | 858.1K | ★ 1.2M |
| Earning Date | 11-10-2025 | 11-05-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | $316,063,000.00 | ★ $450,902,000.00 |
| Revenue This Year | $3.23 | $5.70 |
| Revenue Next Year | N/A | $4.05 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 4.63 | 1.51 |
| 52 Week Low | $2.02 | $0.91 |
| 52 Week High | $8.91 | $2.95 |
| Indicator | HCAT | ARAY |
|---|---|---|
| Relative Strength Index (RSI) | 49.60 | 35.87 |
| Support Level | $2.02 | $1.00 |
| Resistance Level | $3.03 | $1.12 |
| Average True Range (ATR) | 0.23 | 0.07 |
| MACD | 0.06 | 0.02 |
| Stochastic Oscillator | 69.80 | 47.17 |
Health Catalyst Inc provides data and analytics technology and services to healthcare organizations. It has two operating segments. The Technology segment, the key revenue driver, includes data platforms, analytics applications, and support services. This generates revenues mainly from contracts that are cloud-based subscription arrangements, time-based license arrangements, and maintenance and support fees; the Professional Services segment is generally the combination of analytics, implementation, strategic advisory, outsourcing, and improvement services to deliver expertise to its customers to more fully configure and utilize the benefits of the technology offerings.
Accuray Inc is a radiation oncology company that develops, manufactures, sells and supports precise, treatment solutions which set the standard of radiation therapy care with the objective of helping patients live lives. The company's technology, The CyberKnife, is used to treat multiple types of cancer and tumors throughout the body. The CyberKnife Systems automatically track, detect and correct for a tumor and patient movement in real-time during the procedure, enabling delivery of precise, high dose radiation with sub-millimetre accuracy while patients breathe normally, without manual user intervention.